What this test measures
Lambda (λ) is one of the two light-chain classes of immunoglobulins. Plasma cells normally produce a slight excess of light chains over heavy chains, releasing free lambda and free kappa chains into blood. The serum free lambda assay quantifies these free λ chains, reported in mg/L, alongside free kappa and the κ/λ ratio.
Lambda-restricted plasma cell disorders include lambda multiple myeloma, lambda light-chain myeloma, and AL amyloidosis (lambda is more common than kappa in amyloidosis). The κ/λ ratio is more sensitive than absolute lambda alone because the ratio detects monoclonal excess even when both light chains are within their reference ranges.
Why it matters
Serum free lambda is part of the standard panel for diagnosis, prognosis, and monitoring of multiple myeloma, light-chain myeloma, AL amyloidosis, MGUS, and Waldenström macroglobulinaemia. An abnormally low κ/λ ratio (< 0.26) indicates lambda monoclonal excess.
In AL amyloidosis, lambda chains are responsible in roughly 75% of cases — making lambda free light chain especially relevant. Patients with unexplained heart failure (especially with low voltages on ECG and apical sparing on echo), nephrotic syndrome with renal failure, hepatomegaly, peripheral neuropathy, or carpal tunnel syndrome bilaterally should be screened with serum free light chains as part of the amyloidosis workup. In India, AL amyloidosis is increasingly recognised in cardiology and nephrology clinics where it was historically under-diagnosed.
How to prepare
No fasting required. Continue all medications. Disclose any known myeloma, MGUS, amyloidosis, or kidney disease. The lambda test is most informative when reported with free kappa and the κ/λ ratio — order both together.
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| Free Lambda Light Chain (Serum) (mg/L)[1][2][3] | 5.7 – 26.3 mg/L (with κ/λ ratio 0.26 – 1.65; renal range up to 0.37 lower bound) | < 5.7 mg/L: uncommon in isolation. May indicate immune paresis or rarely a kappa-dominant plasma cell disorder (with high κ and suppressed λ). | > 26.3 mg/L with abnormal κ/λ ratio (< 0.26): lambda-producing plasma cell disorder — lambda myeloma, lambda light-chain myeloma, lambda AL amyloidosis. > 26.3 mg/L with normal κ/λ ratio: polyclonal rise — kidney impairment, chronic infection, autoimmune disease. |
Free light chain ratio interpretation
| κ/λ ratio | Interpretation |
|---|---|
| 0.26 – 1.65 | Normal balance (polyclonal) |
| < 0.26 | Lambda monoclonal excess — lambda myeloma, lambda AL amyloid |
| > 1.65 | Kappa monoclonal excess |
| Renal failure with preserved ratio (0.37 – 3.1) | Polyclonal accumulation due to reduced renal clearance |
Frequently asked questions
Why is lambda especially important in AL amyloidosis?
About 75% of AL amyloidosis cases are caused by misfolded lambda light chains depositing as amyloid fibrils in organs. Screening any unexplained heart failure (especially with low ECG voltages), nephrotic syndrome, hepatomegaly, or peripheral neuropathy with serum free light chains has become standard practice.
When is the κ/λ ratio abnormal?
The normal range is 0.26–1.65 in patients with normal kidney function (0.37–3.1 in renal impairment). A ratio outside this range — particularly < 0.26 or > 1.65 — suggests a monoclonal plasma cell process.
Can a normal lambda still hide myeloma?
Yes. Many patients with light-chain myeloma have absolute lambda within the reference range but an abnormal κ/λ ratio. The ratio is much more sensitive than absolute values.
How does kidney function affect this test?
Kidneys clear free light chains, so kappa and lambda both accumulate in renal failure. The ratio is generally preserved (within the extended renal range 0.37–3.1). A ratio outside this range still strongly suggests a plasma cell disorder.
What is the workup after an abnormal κ/λ ratio?
Serum protein electrophoresis (SPEP) and immunofixation, 24-hour urine protein and Bence Jones, complete blood count, calcium, creatinine, β2 microglobulin, albumin, skeletal imaging (low-dose CT or MRI), and bone marrow biopsy in confirmed cases.
How is the test used to monitor treatment?
In light-chain myeloma and AL amyloidosis, the affected free light chain (lambda or kappa) and the κ/λ ratio fall toward normal with effective treatment. A rising affected light chain or worsening ratio suggests relapse, sometimes earlier than SPEP shows.
Do I need to fast?
No fasting required.
Related Immunology tests
Tests commonly ordered alongside LAMBDA LIGHT CHAIN, or that help interpret an unexpected result.
Sources & references
- NCBI StatPearls — Multiple Myeloma · accessed 2026-05-30T00:00:00.000Z
- NIH MedlinePlus — Free Light Chain Test · accessed 2026-05-30T00:00:00.000Z
- Mayo Clinic Labs — Kappa and Lambda Free Light Chains · accessed 2026-05-30T00:00:00.000Z
- IMWG — Diagnostic Criteria for Myeloma · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your LAMBDA LIGHT CHAIN test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book LAMBDA LIGHT CHAIN now